Beyond Achondroplasia

Growing together with Clara

June 30, 2018
by inesp.alves

Vosoritide is now in study in children under 5 years old

BioMarin announced on the 14th June 2018, the first administration of BMN 111 to young children with achondroplasia under 5 years old. (1) This is the BMN 111-206 study, a phase 2 study in Infants and Toddlers.     What … Continue reading

Translate »